C16orf96
gene geneOn this page
Summary
C16orf96 (chromosome 16 open reading frame 96, HGNC:40031) is a protein-coding gene on chromosome 16p13.3, encoding Uncharacterized protein C16orf96 (A6NNT2).
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 40 total — 1 pathogenic
- MANE Select transcript:
NM_001145011
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40031 |
| Approved symbol | C16orf96 |
| Name | chromosome 16 open reading frame 96 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000205832 |
| Ensembl biotype | protein_coding |
| Entrez | 342346 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000444310
RefSeq mRNA: 2 — MANE Select: NM_001145011
NM_001145011, NM_001387219
CCDS: CCDS53986
Canonical transcript exons
ENST00000444310 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001490629 | 4574972 | 4575058 |
| ENSE00001490631 | 4574709 | 4574789 |
| ENSE00001490633 | 4571561 | 4571665 |
| ENSE00001490634 | 4556340 | 4556909 |
| ENSE00001561716 | 4575174 | 4576635 |
| ENSE00001613881 | 4599284 | 4599364 |
| ENSE00001633174 | 4580015 | 4580125 |
| ENSE00001649909 | 4594704 | 4594803 |
| ENSE00001653952 | 4587039 | 4587113 |
| ENSE00001685113 | 4578940 | 4579025 |
| ENSE00001687898 | 4600100 | 4600758 |
| ENSE00001694446 | 4594351 | 4594510 |
| ENSE00001714740 | 4591666 | 4591784 |
| ENSE00001715676 | 4593224 | 4593316 |
| ENSE00001740838 | 4588167 | 4588331 |
| ENSE00001803286 | 4592305 | 4592367 |
Expression profiles
Bgee: expression breadth broad, 59 present calls, max score 75.07.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0400 / max 45.1085, expressed in 4 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 152474 | 0.0241 | 4 |
| 152473 | 0.0159 | 3 |
Top tissues by expression
95 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.07 | silver quality |
| left testis | UBERON:0004533 | 74.65 | gold quality |
| testis | UBERON:0000473 | 74.35 | gold quality |
| right testis | UBERON:0004534 | 73.96 | gold quality |
| cortical plate | UBERON:0005343 | 53.88 | gold quality |
| prefrontal cortex | UBERON:0000451 | 52.81 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 52.76 | gold quality |
| bone marrow cell | CL:0002092 | 52.31 | gold quality |
| substantia nigra | UBERON:0002038 | 52.04 | gold quality |
| ventricular zone | UBERON:0003053 | 51.99 | silver quality |
| granulocyte | CL:0000094 | 51.30 | silver quality |
| frontal cortex | UBERON:0001870 | 50.96 | gold quality |
| putamen | UBERON:0001874 | 50.82 | gold quality |
| nucleus accumbens | UBERON:0001882 | 50.15 | gold quality |
| caudate nucleus | UBERON:0001873 | 50.01 | gold quality |
| liver | UBERON:0002107 | 49.87 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 49.71 | silver quality |
| bone marrow | UBERON:0002371 | 49.43 | gold quality |
| temporal lobe | UBERON:0001871 | 49.42 | gold quality |
| amygdala | UBERON:0001876 | 49.31 | gold quality |
| cerebral cortex | UBERON:0000956 | 49.07 | gold quality |
| ganglionic eminence | UBERON:0004023 | 48.80 | gold quality |
| right lobe of liver | UBERON:0001114 | 48.63 | silver quality |
| primary visual cortex | UBERON:0002436 | 48.56 | silver quality |
| right frontal lobe | UBERON:0002810 | 48.55 | gold quality |
| Ammon’s horn | UBERON:0001954 | 48.37 | gold quality |
| body of pancreas | UBERON:0001150 | 48.22 | silver quality |
| hypothalamus | UBERON:0001898 | 48.14 | gold quality |
| brain | UBERON:0000955 | 48.05 | gold quality |
| pancreas | UBERON:0001264 | 48.05 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.61 |
Regulation
Is transcription factor: no
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zp2l2 | ENSDARG00000004898 |
| danio_rerio | zp2l1 | ENSDARG00000055415 |
| danio_rerio | zpax4 | ENSDARG00000079034 |
| danio_rerio | zp2.1 | ENSDARG00000086352 |
| danio_rerio | zp2.5 | ENSDARG00000086522 |
| danio_rerio | si:zfos-1505d6.3 | ENSDARG00000089966 |
| danio_rerio | zp2.3 | ENSDARG00000090237 |
| danio_rerio | zp2.6 | ENSDARG00000091409 |
| danio_rerio | zp2.2 | ENSDARG00000105346 |
| mus_musculus | 4930562C15Rik | ENSMUSG00000022518 |
| rattus_norvegicus | ENSRNOG00000084991 |
Paralogs (4): ZP2 (ENSG00000103310), ZP4 (ENSG00000116996), QRICH2 (ENSG00000129646), ZP1 (ENSG00000149506)
Protein
Protein identifiers
Uncharacterized protein C16orf96 — A6NNT2 (reviewed: A6NNT2)
All UniProt accessions (1): A6NNT2
RefSeq proteins (2): NP_001138483, NP_001374148 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032013 | DUF4795 | Domain |
Pfam: PF16043
UniProt features (11 total): region of interest 4, compositionally biased region 3, coiled-coil region 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NNT2-F1 | 56.19 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 12 (showing top):
DARWICHE_PAPILLOMA_PROGRESSION_RISK, ZNF664_TARGET_GENES, GSE14026_TH1_VS_TH17_UP, GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN, GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN, GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN, GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP, GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN, chr16p13, GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP, GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP, GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
843 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C16orf96 | ZNF142 | P52746 | 610 |
| C16orf96 | FAM194C | Q8ND61 | 570 |
| C16orf96 | SLC38A11 | Q08AI6 | 551 |
| C16orf96 | GLB1L | Q6UWU2 | 510 |
| C16orf96 | EBLN1 | P0CF75 | 505 |
| C16orf96 | UBALD1 | Q8TB05 | 447 |
| C16orf96 | ZFP69B | Q9UJL9 | 433 |
| C16orf96 | MYCBPAP | Q8TBZ2 | 401 |
| C16orf96 | GPR45 | Q9Y5Y3 | 397 |
| C16orf96 | BEAN1 | Q3B7T3 | 380 |
| C16orf96 | TTC21B | Q7Z4L5 | 371 |
| C16orf96 | NMRAL1 | Q9HBL8 | 352 |
| C16orf96 | WDR46 | O15213 | 349 |
| C16orf96 | ARHGAP39 | Q9C0H5 | 325 |
| C16orf96 | CCDC39 | Q9UFE4 | 323 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PPP1CA | CCDC85C | psi-mi:“MI:0914”(association) | 0.670 |
| GRB2 | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (9): C16orf96 (Affinity Capture-MS), C16orf96 (Affinity Capture-MS), C16orf96 (Affinity Capture-MS), C16orf96 (Affinity Capture-MS), C16orf96 (Affinity Capture-MS), C16orf96 (Proximity Label-MS), C16orf96 (Negative Genetic), C16orf96 (Proximity Label-MS), THRAP3 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A1A5Q6, A6NF34, A6NNT2, B0BF33, D3ZF92, O43278, O75509, O88393, P08920, P08921, P25236, P26342, P35054, P49907, P49908, P51843, P70274, P70503, P79386, Q03167, Q05469, Q13342, Q1LVK9, Q4JF29, Q4R7B7, Q5F378, Q5QGU6, Q5R8W9, Q61066, Q6AY06, Q6P7C7, Q6S545, Q8BHP7, Q8BVM2, Q8VHF2, Q91ZV2, Q921T2, Q96PD2, Q99P91, Q99PS8
Diamond homologs: A6NNT2, E9QMW4, Q3V2A7, Q9H0J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
40 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 685643 | GRCh37/hg19 16p13.3(chr16:3731117-5325699)x3 | Pathogenic |
SpliceAI
2268 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:4556906:CAAGG:C | donor_loss | 1.0000 |
| 16:4556907:AAGGT:A | donor_loss | 1.0000 |
| 16:4556908:AGG:A | donor_loss | 1.0000 |
| 16:4556909:GGTAC:G | donor_loss | 1.0000 |
| 16:4556910:G:C | donor_loss | 1.0000 |
| 16:4556911:T:A | donor_loss | 1.0000 |
| 16:4571559:A:AG | acceptor_gain | 1.0000 |
| 16:4571560:G:GT | acceptor_gain | 1.0000 |
| 16:4571560:GT:G | acceptor_gain | 1.0000 |
| 16:4571560:GTC:G | acceptor_gain | 1.0000 |
| 16:4571560:GTCA:G | acceptor_gain | 1.0000 |
| 16:4571560:GTCAA:G | acceptor_gain | 1.0000 |
| 16:4571663:AAGGT:A | donor_loss | 1.0000 |
| 16:4571664:AGGT:A | donor_loss | 1.0000 |
| 16:4571666:G:C | donor_loss | 1.0000 |
| 16:4571667:T:A | donor_loss | 1.0000 |
| 16:4574704:GACAG:G | acceptor_loss | 1.0000 |
| 16:4574707:A:AG | acceptor_gain | 1.0000 |
| 16:4574707:AGGTA:A | acceptor_loss | 1.0000 |
| 16:4574708:G:GG | acceptor_gain | 1.0000 |
| 16:4574784:G:GT | donor_gain | 1.0000 |
| 16:4574784:G:T | donor_gain | 1.0000 |
| 16:4574786:AGTGG:A | donor_loss | 1.0000 |
| 16:4574787:GTG:G | donor_gain | 1.0000 |
| 16:4574788:TGG:T | donor_loss | 1.0000 |
| 16:4574790:G:GA | donor_loss | 1.0000 |
| 16:4574791:T:G | donor_loss | 1.0000 |
| 16:4575054:CCTCA:C | donor_gain | 1.0000 |
| 16:4575055:CTCA:C | donor_gain | 1.0000 |
| 16:4575059:GTGA:G | donor_gain | 1.0000 |
AlphaMissense
7440 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:4575026:T:A | W221R | 0.978 |
| 16:4575026:T:C | W221R | 0.978 |
| 16:4556518:T:C | L10P | 0.976 |
| 16:4575028:G:C | W221C | 0.975 |
| 16:4575028:G:T | W221C | 0.975 |
| 16:4576600:T:C | L707P | 0.975 |
| 16:4576612:T:C | L711P | 0.975 |
| 16:4556530:C:A | A14D | 0.973 |
| 16:4576528:T:A | V683D | 0.968 |
| 16:4579006:T:C | L741P | 0.968 |
| 16:4574979:T:C | L205P | 0.966 |
| 16:4576524:G:C | A682P | 0.966 |
| 16:4575050:T:C | F229L | 0.965 |
| 16:4575052:C:A | F229L | 0.965 |
| 16:4575052:C:G | F229L | 0.965 |
| 16:4571595:T:C | L152P | 0.964 |
| 16:4580100:T:C | L776P | 0.963 |
| 16:4571586:T:C | L149P | 0.962 |
| 16:4571604:T:C | L155P | 0.958 |
| 16:4591777:T:C | F902L | 0.957 |
| 16:4591779:T:A | F902L | 0.957 |
| 16:4591779:T:G | F902L | 0.957 |
| 16:4574776:T:C | L198P | 0.954 |
| 16:4587106:T:C | L807P | 0.953 |
| 16:4576192:C:A | A571D | 0.950 |
| 16:4576536:T:C | S686P | 0.950 |
| 16:4571625:T:C | L162P | 0.947 |
| 16:4575036:T:C | L224P | 0.947 |
| 16:4556578:T:C | L30P | 0.946 |
| 16:4576579:T:C | L700P | 0.946 |
dbSNP variants (sampled 300 via entrez): RS1000006921 (16:4571351 A>G), RS1000046113 (16:4537465 G>A), RS1000064970 (16:4549846 C>G), RS1000110160 (16:4542030 G>C), RS1000115649 (16:4576524 G>A,C,T), RS1000143909 (16:4590634 C>T), RS1000151492 (16:4576343 A>C), RS1000160457 (16:4571921 C>A), RS1000197255 (16:4556950 C>T), RS1000256150 (16:4596062 G>A,C,T), RS1000283760 (16:4551842 A>C,G), RS1000297333 (16:4548597 G>A), RS1000367467 (16:4566080 C>T), RS1000419468 (16:4546177 G>C,T), RS1000420566 (16:4551550 C>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_670 | Obesity-related traits | 7.000000e-07 |
| GCST90002394_533 | Monocyte percentage of white cells | 1.000000e-09 |
| GCST90002402_176 | Platelet count | 2.000000e-09 |
| GCST90020024_739 | A body shape index | 2.000000e-10 |
| GCST90020024_740 | A body shape index | 4.000000e-08 |
| GCST90020029_562 | Waist circumference adjusted for body mass index | 8.000000e-09 |
| GCST90020029_563 | Waist circumference adjusted for body mass index | 4.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005119 | antioxidant measurement |
| EFO:0007989 | monocyte percentage of leukocytes |
| EFO:0004309 | platelet count |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases mutagenesis | 3 |
| propionaldehyde | decreases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| Sunitinib | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.